These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17897004)

  • 1. 5-hydroxytryptamine (5-HT) receptor ligands.
    Kitson SL
    Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and Therapeutic Potential of the 5-HT
    Blattner KM; Canney DJ; Pippin DA; Blass BE
    ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
    Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.
    Perez M; Jorand-Lebrun C; Pauwels PJ; Pallard I; Halazy S
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1407-12. PubMed ID: 9871775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latest advances towards the discovery of 5-HT(7) receptor ligands.
    Pittala V; Pittala D
    Mini Rev Med Chem; 2011 Nov; 11(13):1108-21. PubMed ID: 22353220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptors and therapeutics.
    Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of 5-HT Receptors Using Radioligand-Binding Autoradiography.
    Cortés R; Vilaró MT; Mengod G
    Curr Protoc Pharmacol; 2016 Dec; 75():8.3.1-8.3.20. PubMed ID: 27960027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
    Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
    Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of 5-HT receptors.
    Hannon J; Hoyer D
    Behav Brain Res; 2008 Dec; 195(1):198-213. PubMed ID: 18571247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
    Dukat M; Choi YN; Teitler M; Du Pre A; Herrick-Davis K; Smith C; Glennon RA
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1599-603. PubMed ID: 11412989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic overview of new molecules with 5-HT1A binding affinities.
    Pessoa-Mahana H; Araya-Maturana R; Saitz CB; Pessoa-Mahana DC
    Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders.
    Ohno Y
    Cent Nerv Syst Agents Med Chem; 2010 Jun; 10(2):148-57. PubMed ID: 20518729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT1A receptor and its ligands: structure and function.
    Olivier B; Soudijn W; van Wijngaarden I
    Prog Drug Res; 1999; 52():103-65. PubMed ID: 10396127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical update on the potential for serotonin 5-HT
    Kucwaj-Brysz K; Baltrukevich H; Czarnota K; Handzlik J
    Bioorg Med Chem Lett; 2021 Oct; 49():128275. PubMed ID: 34311086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting 5-HT receptors for the treatment of obesity.
    Sargent BJ; Henderson AJ
    Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin receptors: subtypes, functional responses and therapeutic relevance.
    Saxena PR
    Pharmacol Ther; 1995 May; 66(2):339-68. PubMed ID: 7667401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.